Advertisement
Advertisement

JBIO

J

Jade Biosciences, Inc. Common Stock

25.07
USD
Sponsored
-0.16
-0.63%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

25.11

+0.04
+0.16%

Jade Biosciences, Inc. Common Stock Profile

About

Jade Biosciences Inc. is focused on developing therapies to address critical unmet needs in autoimmune diseases. The company pipeline includes antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade Biosciences Inc., formerly known as Aerovate Therapeutics Inc., is based in WALTHAM, Mass.

Info & Links

CEO

Tom Frohlich

Headquarters

221 Crescent Street, Building 23, Suite 105
Waltham, MA 02453, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://jadebiosciences.com

Auditor

PricewaterhouseCoopers LLP

Share holders

78

Employees

55

Jade Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.24B

Enterprise Value

1.15B

Enterprise Value/EBITDA(ttm)

-10.07

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.70

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-46.55%

Return on Invested Capital(ttm)

-53.66%

Return on Assets(ttm)

-42.99%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-114.30M

Net Income Available to Common(ttm)

-100.14M

Diluted EPS(ttm)

-4.61

Share Statistics

Beta (5Y Monthly)

1.03

52-Week Change

191.17%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

49.32M

Dividend Yield

0.00%

Float4

37.04M

% Held by Insiders

24.90%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

336.16M

Total Cash Per Share(mrq)

6.82

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

21.09%

Quick Ratio(mrq)

21.09%

Book Value Per Share(mrq)

6.74

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.02

Free Cash Flow(ytd)

-94.89M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement